Risk Factors for Foot Infections in Individuals with Diabetes
Overview
Authors
Affiliations
Objective: To prospectively determine risk factors for foot infection in a cohort of people with diabetes.
Research Design And Methods: We evaluated then followed 1,666 consecutive diabetic patients enrolled in a managed care-based outpatient clinic in a 2-year longitudinal outcomes study. At enrollment, patients underwent a standardized general medical examination and detailed foot assessment and were educated about proper foot care. They were then rescreened at scheduled intervals and also seen promptly if they developed any foot problem.
Results: During the evaluation period, 151 (9.1%) patients developed 199 foot infections, all but one involving a wound or penetrating injury. Most patients had infections involving only the soft tissue, but 19.9% had bone culture-proven osteomyelitis. For those who developed a foot infection, compared with those who did not, the risk of hospitalization was 55.7 times greater (95% CI 30.3-102.2; P < 0.001) and the risk of amputation was 154.5 times greater (58.5-468.5; P < 0.001). Foot wounds preceded all but one infection. Significant (P < 0.05) independent risk factors for foot infection from a multivariate analysis included wounds that penetrated to bone (odds ratio 6.7), wounds with a duration >30 days (4.7), recurrent wounds (2.4), wounds with a traumatic etiology (2.4), and presence of peripheral vascular disease (1.9).
Conclusions: Foot infections occur relatively frequently in individuals with diabetes, almost always follow trauma, and dramatically increase the risk of hospitalization and amputation. Efforts to prevent infections should be targeted at people with traumatic foot wounds, especially those that are chronic, deep, recurrent, or associated with peripheral vascular disease.
Lee M, Hua Y, Toh H, Su H, Chen P Diab Vasc Dis Res. 2025; 22(1):14791641241311293.
PMID: 39931793 PMC: 11811984. DOI: 10.1177/14791641241311293.
Revisiting Antibiotic-Impregnated Cement Spacer for Diabetic Osteomyelitis of the Foot.
Khury F, Karkabi I, Mazzawi E, Norman D, Melamed E, Peled E Antibiotics (Basel). 2025; 13(12.
PMID: 39766543 PMC: 11672849. DOI: 10.3390/antibiotics13121153.
Antibiotic and Surgical Treatment of Diabetic Foot Osteomyelitis: The Histopathological Evidence.
Da Ros R, Assaloni R, Michelli A, Brunato B, Miranda C Antibiotics (Basel). 2025; 13(12.
PMID: 39766532 PMC: 11672856. DOI: 10.3390/antibiotics13121142.
Deciphering pathogenicity and virulence of the first isolate from diabetic foot osteomyelitis.
Abi Najem C, Magnan C, Plumet L, Ahmad-Mansour N, Pouget C, Morsli M Front Cell Infect Microbiol. 2025; 14:1489280.
PMID: 39742337 PMC: 11685071. DOI: 10.3389/fcimb.2024.1489280.
Re-infection after treatment for moderate and severe diabetic foot infections.
Lavery L, Tarricone A, Ryan E, Crisologo P, Malone M, Suludere M Int Wound J. 2024; 21(11):e70123.
PMID: 39567214 PMC: 11578675. DOI: 10.1111/iwj.70123.